Abstract

West Nile Virus (WNV), a zoonotic mosquito-borne virus (mobovirus) originally isolated from the blood of a febrile Ugandan woman in 1937, caused substantial human disease in Europe starting in the 1990s and emerged in 1999 in The United States of America (USA) for the first time. It has become an important concern for public health due to its reemergence and frequent human outbreaks. The enzootic transmission cycle of arboviruses involves primary wild animals; however, spillover transmission is reported frequently in domestic animals. Dogs are dead-end hosts in WNV transmission epidemiology. However, detecting WNV antibodies in the dog population can indicate the virus’s presence and spread in different areas. The virus is known to be endemic in parts of Romania, including Iași County. The study aimed at assessing the prevalence of anti-WNV antibodies in indoor dogs from an urban area in Iași, where all the conditions for virus transmission are met (wetland, density of wildlife hosts including birds, abundance of vectors, domestic mammal hosts and synanthropic birds). Using a commercial enzyme-linked immunosorbent assay (INGEZIM West Nile COMPAC, Ingenasa, Madrid, Spain), serum samples collected from indoor dogs between 2020–2022 were screened for WNV antibodies. The results showed an overall seroprevalence of 12.2%. Detection of specific antibodies in dogs suggests a possible establishment of an urban cycle for WNV or other antigenically related flaviviruses.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.